Daejeon, South Korea

Sook Kyung Yoon

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Lg Chem, Ltd. Active years: 2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sook Kyung Yoon. Retrieved from https://idiyas.com/inventor/sook-kyung-yoon-urkmf7l3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sook Kyung Yoon: Innovator in Diabetes Treatment

Introduction

Sook Kyung Yoon is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. Her innovative work focuses on developing compounds that can effectively manage blood sugar levels.

Latest Patents

Sook Kyung Yoon holds a patent for a GPR40 receptor agonist, which includes methods of preparing the compound and pharmaceutical compositions containing it as an active agent. This novel compound promotes insulin secretion and inhibits blood sugar rise after glucose loading. It is particularly useful for treating diabetes and its complications.

Career Highlights

Yoon is associated with LG Chem, Ltd., a leading chemical company known for its advancements in various sectors, including pharmaceuticals. Her work at LG Chem has allowed her to explore innovative solutions to pressing health issues.

Collaborations

She has collaborated with notable colleagues, including Sung Bae Lee and Seung Yup Paek, to further her research and development efforts in the pharmaceutical field.

Conclusion

Sook Kyung Yoon's contributions to diabetes treatment through her innovative patent highlight her role as a key inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in managing diabetes effectively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…